These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1922892)

  • 1. [Tolerability to terizidone (TZ) in the treatment of pulmonary tuberculosis in dialyzed patients].
    Galietti F; Giorgis GE; Oliaro A; Boaro D; Ardizzi A; Barberis S; Massaglia GM
    Minerva Med; 1991; 82(7-8):477-81. PubMed ID: 1922892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance].
    Shmelev NA; Shabalova LN; Kolosovskaia VP
    Antibiotiki; 1975 Feb; 20(2):174-80. PubMed ID: 1091207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Terizidone in the therapy of chronic pulmonary tuberculosis].
    Fossati C
    G Ital Mal Torace; 1971; 25(4):195-204. PubMed ID: 5141834
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary note on Terizidone].
    Dumon JF; Aimone J; Dumon G
    Mars Med; 1972; 109(11):730-2. PubMed ID: 4662237
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of clinical trials of a new antitubercular agent, terizidone (Terivalidine)].
    Zrilić V; Mijatović M; Mirković S; Muzikravić T
    Plucne Bolesti Tuberk; 1972; 24(2):89-98. PubMed ID: 4565191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary experiences with treatment of pulmonary tuberculosis with 1',4'-bis-D-(3-oxo-4-isoxazolidinyliminomethyl)-benzene (Terizidone)].
    Scarponi F; Dorigoni A
    Arch Maragliano Patol Clin; 1968; 24(4):457-70. PubMed ID: 5755799
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cycloserine and terizidone in the treatment of pulmonary tuberculosis: clinical study of tolerance].
    Rizzo A; Gomes A; Antunes G
    Rev Bras Med; 1969 Feb; 26(2):119-22. PubMed ID: 5797682
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
    Reichlin S; Frei R; Reusser P
    Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therizidone in the treatment of chronic pulmonary tuberculosis. (Report of clinical trials)].
    Meo G; Cernetti B; Zordan M
    G Ital Mal Torace; 1969; 23(3):135-48. PubMed ID: 5355950
    [No Abstract]   [Full Text] [Related]  

  • 16. [Terisidon in chemotherapy of pulmonary tuberculosis].
    Kolosovskaia VP; Korotaev GA
    Probl Tuberk; 1974; (12):15-8. PubMed ID: 4445129
    [No Abstract]   [Full Text] [Related]  

  • 17. [New-onset pulmonary tuberculosis patients with schizophrenia: course and efficiency of treatment].
    Mishin VIu; Shevchuk EIu; Tsygankov BD; Losev LV
    Probl Tuberk Bolezn Legk; 2008; (6):6-10. PubMed ID: 18710046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of the chemotherapy of patients with chronic destructive pulmonary tuberculosis].
    Zakupra NI; Khomenko VV
    Vrach Delo; 1989 Nov; (11):41-2. PubMed ID: 2609584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of pulmonary Mycobacterium kansasii infection].
    Mizutani S
    Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Terizidone in the therapy of tubercular orchiepididymitis].
    Vivenzio L
    Arch Tisiol Mal Appar Respir; 1968 Dec; 23(12):1001-6. PubMed ID: 5305705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.